EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

66 hedge funds and large institutions have $85.6M invested in EyePoint Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 16 closing their positions.

Holders
66
Holders Change
-8
Holders Change %
-10.81%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
19
Reduced
19
Closed
16
Calls
$213K
Puts
$36K
Net Calls
+$177K
Net Calls Change
-$27K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.7M
2
CAM
2
Cormorant Asset Management
Massachusetts
$662K
3
Squarepoint
3
Squarepoint
New York
$193K
4
Morgan Stanley
4
Morgan Stanley
New York
$263K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$210K

Top Sellers

1
O
1
OrbiMed
New York
$0
2
BlackRock
2
BlackRock
New York
$4.48M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$0
4
Tudor Investment Corp
4
Tudor Investment Corp
Connecticut
$0
5
Verition Fund Management
5
Verition Fund Management
Connecticut
$1.43M
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– -$26K -7,681 Closed
Federated Hermes
77
Federated Hermes
Pennsylvania
– -$14.2K -4,055 Closed
PMEF
78
Point72 Middle East FZE
United Arab Emirates
– -$4.33K -1,237 Closed
Citigroup
79
Citigroup
New York
– -$616 -176 Closed
NA
80
NewEdge Advisors
Louisiana
– -$231 -66 Closed
CS
81
Credit Suisse
Switzerland
– -$4 -1 Closed
1 2 3
4